cefazolin

Product NDC
25021-100
11-digit product format
250210100
Labeler code
25021
Product ID
25021-100_6dfa594e-90e8-4085-af30-6d3660a6bebf
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
cefazolin sodium
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Labeler
Sagent Pharmaceuticals
Application
ANDA065303
Marketing category
ANDA
Marketing start
2009-02-01
Marketing end
0000-00-00
Substance
CEFAZOLIN SODIUM
Active strength
500 mg/2.2mL
Pharmacologic classes
Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
25021-100-10EA - Each25021-100bf5930ee-e2b1-48ae-bee7-b4720f8ad04512012-07-24
25021-100-66EA - Each25021-1003f29c7cf-2754-45b1-86dd-66567b28718812015-07-20

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
cefazolin sodiumACTIVE INGREDIENTP380M0454ZCEFAZOLIN (CEFAZOLIN SODIUM) INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS]7
cefazolinACTIVE MOIETYIHS69L0Y4TCEFAZOLIN (CEFAZOLIN SODIUM) INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS]7

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
25021-100CEFAZOLIN (CEFAZOLIN SODIUM) INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS]14Legacy NDC20240302_e8f40f72-3cf0-43dc-a797-fb98dd8af228.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
25021-100-102502101001025 VIAL in 1 CARTON (25021-100-10) > 2.2 mL in 1 VIAL25 vial2009-02-010000-00-00NoNoCurrent
25021-100-662502101006625 VIAL in 1 CARTON (25021-100-66) > 2.2 mL in 1 VIAL25 vial2015-07-010000-00-00NoNoCurrent